Influence of short‐term dexamethasone on the efficacy of 177 Lu‐PSMA‐617 in patients with metastatic castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Influence of short‐term dexamethasone on the efficacy of 177 Lu‐PSMA‐617 in patients with metastatic castration‐resistant prostate cancer

Published:2020-03-18 Issue:8 Volume:80 Page:619-631
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Derlin Thorsten¹^ORCID,Sommerlath Sohns Jan M.¹,Schmuck Sebastian¹²,Henkenberens Christoph³,Klot Christoph A. J.⁴,Ross Tobias L.¹,Bengel Frank M.¹

Affiliation:

1. Department of Nuclear MedicineHannover Medical School Hannover Germany

2. Department of RadiologyDIAKOVERE Friederikenstift Hannover Germany

3. Department of Radiation OncologyHannover Medical School Hannover Germany

4. Department of Urology and Urologic OncologyHannover Medical School Hannover Germany

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23974

Reference29 articles.

1. Global cancer statistics, 2012

2. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

3. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

4. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

5. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617 Radioligand Therapy;Indian Journal of Radiology and Imaging;2024-02-23

2. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT);European Journal of Nuclear Medicine and Molecular Imaging;2023-05-29

3. PSMA‐heterogeneity in metastatic castration‐resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy;The Prostate;2023-05-05

4. Pharmacological Optimization of PSMA-Based Radioligand Therapy;Biomedicines;2022-11-23

5. ¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer;Journal of Nuclear Medicine;2022-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3